Building Resiliency and Vital Equity (BRAVE) Project: Understanding Native Americans' Perceptions/Beliefs About COVID-19 Testing and Vaccination Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04964154

Acronym

BRAVE

Enrollment

4000

Registered

2021-07-15

Start date

2021-02-17

Completion date

2022-06-30

Last updated

2021-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19 Virus Infection

Keywords

COVID-19 testing

Brief summary

The Building Resilience and Vital Equity (BRAVE) project seeks to partner with American Indian tribal communities in North Carolina to establish COVID-19 services and resources for American Indian communities. The goal of this study is to 1) understand the barriers and social implications of COVID19 testing and vaccination among American Indians by designing and implementing culturally sensitive survey tools and intervention materials; 2) Implement BRAVE outreach and testing interventions to increase testing in American Indian communities; 3) analyze data and share back with tribal communities to improve perceptions of COVID-19 testing in the AI community and decrease in vaccine hesitancy.

Interventions

BEHAVIORALProtect Your Elders Campaign

This is a behavioral intervention where participants will receive cultural appropriate educational information about COVID-19 testing and vaccination.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SCREENING

Masking

NONE

Masking description

No masking employed in this study.

Intervention model description

Participants will be randomized to receive information about testing and vaccination based on zip code.

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

\- Self reports as Native American or American Indian

Exclusion criteria

* Does not self-report as Native American or American Indian

Design outcomes

Primary

Measure	Time frame	Description
Increase in COVID-19 testing	1 month	Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get tested for COVID-19.
Increase in COVID-19 vaccination	1 month	Survey responses to determine if participants in zipcodes selected for intervention are more less inclined to get vaccinated against COVID-19.

Countries

United States

Contacts

Primary ContactDeepak Kumar, PhD

dkumar@ad.nccu.edu919-530-7017

Backup ContactTracie Locklear

tlockl12@nccu.edu9195306251

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026